272 related articles for article (PubMed ID: 28341124)
1. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
[TBL] [Abstract][Full Text] [Related]
2. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
Yang Z; Ni W; Cui C; Fang L; Xuan Y
Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
[TBL] [Abstract][Full Text] [Related]
4. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis.
Qi W; Yang Z; Li H; Cui Y; Xuan Y
APMIS; 2019 Feb; 127(2):64-71. PubMed ID: 30698309
[TBL] [Abstract][Full Text] [Related]
5. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
7. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs.
Shen C; Wang C; Yin Y; Chen H; Yin X; Cai Z; Chen Z; Zhang B; Zhou Z
Medicine (Baltimore); 2019 Jan; 98(2):e14045. PubMed ID: 30633201
[TBL] [Abstract][Full Text] [Related]
10. miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma.
Xu S; Yi XM; Zhang ZY; Ge JP; Zhou WQ
Mol Med Rep; 2016 Dec; 14(6):5025-5032. PubMed ID: 27779679
[TBL] [Abstract][Full Text] [Related]
11. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
Wawrzyniak D; Grabowska M; Głodowicz P; Kuczyński K; Kuczyńska B; Fedoruk-Wyszomirska A; Rolle K
PLoS One; 2020; 15(8):e0237889. PubMed ID: 32817625
[TBL] [Abstract][Full Text] [Related]
14. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
[TBL] [Abstract][Full Text] [Related]
18. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
Murakami T; Kikuchi H; Ishimatsu H; Iino I; Hirotsu A; Matsumoto T; Ozaki Y; Kawabata T; Hiramatsu Y; Ohta M; Kamiya K; Fukushima M; Baba S; Kitagawa K; Kitagawa M; Konno H
Br J Cancer; 2017 Oct; 117(9):1360-1370. PubMed ID: 29065427
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum tenascin-C levels in breast cancer.
Tastekin D; Tas F; Karabulut S; Duranyildiz D; Serilmez M; Guveli M; Vatansever S
Tumour Biol; 2014 Jul; 35(7):6619-25. PubMed ID: 24696262
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of cancer-associated fibroblasts and their correlation with microvessel and lymphatic vessel density in lung adenocarcinoma.
Chen L; Qin Y; Zhang T; Ding N; Chen Y; Zhang Z; Guo C
J Clin Lab Anal; 2019 May; 33(4):e22832. PubMed ID: 30737838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]